Editas Medicine (EDIT) EBT Margin (2016 - 2025)
Historic EBT Margin for Editas Medicine (EDIT) over the last 11 years, with Q3 2025 value amounting to 332.97%.
- Editas Medicine's EBT Margin rose 1015293200.0% to 332.97% in Q3 2025 from the same period last year, while for Sep 2025 it was 426.12%, marking a year-over-year decrease of 851800.0%. This contributed to the annual value of 733.71% for FY2024, which is 5396300.0% down from last year.
- Per Editas Medicine's latest filing, its EBT Margin stood at 332.97% for Q3 2025, which was up 1015293200.0% from 1438.71% recorded in Q2 2025.
- In the past 5 years, Editas Medicine's EBT Margin ranged from a high of 31.41% in Q4 2023 and a low of 132683.33% during Q3 2022
- Its 5-year average for EBT Margin is 14653.19%, with a median of 873.2% in 2021.
- Per our database at Business Quant, Editas Medicine's EBT Margin crashed by -1320523700bps in 2022 and then soared by 1318396500bps in 2023.
- Quarter analysis of 5 years shows Editas Medicine's EBT Margin stood at 332.3% in 2021, then crashed by -180bps to 929.22% in 2022, then surged by 97bps to 31.41% in 2023, then tumbled by -372bps to 148.32% in 2024, then tumbled by -124bps to 332.97% in 2025.
- Its EBT Margin stands at 332.97% for Q3 2025, versus 1438.71% for Q2 2025 and 1624.37% for Q1 2025.